Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 13.75
0.00 (0.00%)
Aug 14, 2026, 2:47 PM GMT
Ondine Biomedical Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -29.52 | -19.1 | -14.41 | -19.37 | -50.09 |
Depreciation & Amortization | 0.59 | 0.57 | 0.59 | 0.49 | 0.51 |
Other Amortization | - | - | - | 1.33 | - |
Loss (Gain) From Sale of Assets | - | - | 0.1 | 0.08 | - |
Stock-Based Compensation | 1.73 | 1.85 | 0.64 | 1.45 | 4.06 |
Other Operating Activities | -0.45 | -0.72 | -0.27 | -0.43 | 32.84 |
Change in Accounts Receivable | 0.05 | -0.19 | -0.14 | 0.07 | 0.3 |
Change in Inventory | -1.03 | -0.33 | 0.1 | -0.34 | -0.67 |
Change in Accounts Payable | 4.8 | 2.53 | -0.42 | 0.25 | 2.15 |
Change in Other Net Operating Assets | -0.03 | -0.11 | 0.16 | 0.13 | -1.65 |
Operating Cash Flow | -23.85 | -15.49 | -13.65 | -16.35 | -12.54 |
Operating Cash Flow Growth | - | - | - | - | - |
Capital Expenditures | -0.12 | -0.01 | -0.18 | -0.31 | -0.08 |
Investing Cash Flow | -0.12 | -0.01 | -0.18 | -0.31 | -0.08 |
Short-Term Debt Issued | - | 1.65 | - | - | 2.83 |
Long-Term Debt Issued | - | - | - | - | 4.25 |
Total Debt Issued | - | 1.65 | - | - | 7.08 |
Short-Term Debt Repaid | - | -0.54 | - | - | -0.65 |
Long-Term Debt Repaid | -0.38 | -0.43 | -0.43 | -0.25 | -0.29 |
Total Debt Repaid | -0.38 | -0.96 | -0.43 | -0.25 | -0.94 |
Net Debt Issued (Repaid) | -0.38 | 0.69 | -0.43 | -0.25 | 6.14 |
Issuance of Common Stock | 25.98 | 22.98 | 4.91 | - | 37.73 |
Repurchase of Common Stock | - | - | - | - | -0.8 |
Other Financing Activities | -1.38 | -1.93 | -0.7 | -0.02 | -1.17 |
Financing Cash Flow | 24.22 | 21.74 | 3.79 | -0.28 | 41.9 |
Foreign Exchange Rate Adjustments | 0.39 | 0.55 | -0.09 | 0.34 | -0.05 |
Net Cash Flow | 0.64 | 6.79 | -10.13 | -16.6 | 29.24 |
Free Cash Flow | -23.96 | -15.5 | -13.83 | -16.66 | -12.62 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -905.67% | -756.47% | -1149.63% | -2610.66% | -491.13% |
Free Cash Flow Per Share | -0.05 | -0.06 | -0.07 | -0.09 | -0.16 |
Levered Free Cash Flow | -12.11 | -7.75 | -8.44 | -7.88 | -6.11 |
Unlevered Free Cash Flow | -12.09 | -7.73 | -8.41 | -7.86 | -6.11 |
Cash Interest Paid | - | 0.01 | - | 0.02 | - |
Change in Working Capital | 3.8 | 1.91 | -0.3 | 0.1 | 0.13 |